论文部分内容阅读
隐球菌病是由隐球菌感染引起的深部真菌病,可感染人体的任何组织和脏器,最常见的是中枢神经系统,其次为肺部,尚可累及皮肤、骨骼系统、血液等~([1])。有研究显示,在免疫功能正常的人群中,隐球菌感染率约为十万分之一;在免疫抑制的患者中,隐球菌发病率约5%~10%;而在艾滋病患者中,隐球菌感染率高达30%~([2])。本文主要回顾临床药师对1例肺隐球菌术后患者进行用药前评估,全程参与药物治疗并实施监护,
Cryptococcosis is a deep mycosis caused by cryptococcosis and can infect any tissues and organs of the body, most commonly the central nervous system, followed by the lungs, yet involving the skin, skeletal system, blood, 1]). Studies have shown that in people with normal immune function, cryptococcal infection rate of about one hundred thousandth; in immunosuppressed patients, the incidence of cryptococcal about 5% to 10%; in AIDS patients, cryptococcal Infection rate as high as 30% ~ ([2]). This article reviews the clinical pharmacists in patients with pulmonary cryptococcosis after a preoperative medication evaluation, full participation in drug treatment and implementation of custody,